Total Funding
65
65
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68185
Maxwell Biomedical is developing the 1st of its kind device designed to treat every episode of AF imperceptible to patient
Randy Werneth: Chief Executive OfficerPast Role: Acutus Medical, President and Chief Executive Officer- Randy Werneth: Chief Executive OfficerPast Role: Acutus Medical, President and Chief Executive Officer
About the Company
Maxwell Biomedical is developing the first of its kind device designed to deliver imperceptible, shock-free termination of each, and every episode of atrial fibrillation.
Maxwell device monitors, diagnoses and if AF is detected, performs anti-AFib pacing called SRT to restore normal sinus rhythm.
Fully Integrated AF Care System | Spatial
Resynchronization Therapy and Patient Management - Only Technology to Monitoring, Diagnose AF and Deliver Imperceptible Therapy - Detect & convert AF back to SR -> Reduce AF Density/Burden, slow or stop disease progression - Cloud-based tele-health and remote patient management
